What is BioIntelligence Technologies?
BioIntelligence Technologies specializes in developing and commercializing advanced instruments and software designed to monitor, understand, predict, and optimize bioprocess performances. Their product suite includes the BiOptic+ for real-time bioprocess variable measurement and the BioAnalyst for in-depth data analysis. The company targets organizations within the biomanufacturing sector, aiming to enhance process efficiency, reduce variability, and optimize fermentation processes. By providing intelligent solutions, BioIntelligence Technologies empowers clients to improve overall performance and achieve long-term success in intelligent biomanufacturing.
How much funding has BioIntelligence Technologies raised?
BioIntelligence Technologies has raised a total of $5M across 1 funding round:
Other Financing Round
$5M
Other Financing Round (2024): $5M with participation from Real Ventures, AQC Capital, Investissement Quebec, Amplify Capital, and Innospark Ventures
Key Investors in BioIntelligence Technologies
Real Ventures
Real Ventures is a venture capital firm established in 2007 that backs visionary founders building innovative tech companies with large-scale positive impacts on society, providing guidance and stage-specific help for global success.
AQC Capital
AQC Capital invests in promising startup teams across all industries, providing financial support and guidance from early stages to market success with over $160 million under management.
Investissement Quebec
Investissement Quebec, founded in 1998, assists in the growth of investment in Quebec and contributes to economic development and job creation by offering businesses a full range of financial solutions.
What's next for BioIntelligence Technologies?
With this recent strategic investment, BioIntelligence Technologies is poised for significant expansion. The company's focus on enhancing bioprocess efficiency and performance aligns with the growing demand for advanced analytics and real-time monitoring in the biomanufacturing industry. Future developments are likely to involve scaling production, expanding market reach, and further innovating their software and hardware offerings to maintain a competitive edge. The backing from prominent investors suggests a strong belief in the company's potential to lead in intelligent biomanufacturing solutions.
See full BioIntelligence Technologies company page
